바로가기메뉴

본문 바로가기 주메뉴 바로가기

Incidence and Risk Factors of Pneumonia in Hospitalized Patients with Seasonal Influenza A or B

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2017, v.80 no.4, pp.392-400








  • Downloaded
  • Viewed

Abstract

Background: Most patients with influenza recover spontaneously or following treatment with an anti-viral agent, but some patients experience pneumonia requiring hospitalization. We conducted a retrospective review to determine the incidence and risk factors of pneumonia in hospitalized patients with influenza A or B. Methods: A total of 213 patients aged 18 years or older and hospitalized with influenza between January 2012 and January 2015 were included in this study. A reverse-transcriptase polymerase chain reaction assay was used to detect the influenza A or B virus in the patients’ sputum samples. We collected demographic and laboratory data, combined coexisting diseases, and radiologic findings. Results: The incidence of pneumonia was higher in patients in the influenza A group compared to those in the influenza B group (68.6% vs. 56.9%), but this difference was not statistically significant. The presence of underlying respiratory disease was significantly associated with pneumonia in the influenza A group (adjusted odds ratio [OR], 3.975; 95% confidence interval [CI], 1.312–12.043; p=0.015). In the influenza B group, the white blood cell count (adjusted OR, 1.413; 95% CI, 1.053–1.896; p=0.021), platelet count (adjusted OR, 0.988; 95% CI, 0.978–0.999; p=0.027), and existence of an underlying medical disease (adjusted OR, 15.858; 95% CI, 1.757–143.088; p=0.014) were all significantly associated with pneumonia in multivariate analyses. Conclusion: The incidence of pneumonia was 65.7% in hospitalized patients with influenza A or B. The risk factors of pneumonia differed in hospitalized patients with influenza A or B.

keywords
Pneumonia, Influenza, Risk Factors, Comorbidity

Reference

1.

1. Wie SH, So BH, Song JY, Cheong HJ, Seo YB, Choi SH, et al. A comparison of the clinical and epidemiological characteristics of adult patients with laboratory-confirmed influenza A or B during the 2011-2012 influenza season in Korea: a multicenter study. PLoS One 2013;8:e62685.

2.

2. Glezen WP. Asthma, influenza, and vaccination. J Allergy Clin Immunol 2006;118:1199-206.

3.

3. Mallia P, Johnston SL. Influenza infection and COPD. Int J Chron Obstruct Pulmon Dis 2007;2:55-64.

4.

4. Mamas MA, Fraser D, Neyses L. Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol 2008;130:304-9.

5.

5. Simmerman JM, Chittaganpitch M, Levy J, Chantra S, Maloney S, Uyeki T, et al. Incidence, seasonality and mortality associated with influenza pneumonia in Thailand: 2005-2008. PLoS One 2009;4:e7776.

6.

6. Thompson WW, Weintraub E, Dhankhar P, Cheng PY, Brammer L, Meltzer MI, et al. Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir Viruses 2009;3:37-49.

7.

7. Murata Y, Walsh EE, Falsey AR. Pulmonary complications of interpandemic influenza A in hospitalized adults. J Infect Dis 2007;195:1029-37.

8.

8. Oliveira EC, Marik PE, Colice G. Influenza pneumonia: a descriptive study. Chest 2001;119:1717-23.

9.

9. Ruf BR, Szucs T. Reducing the burden of influenza-associated complications with antiviral therapy. Infection 2009;37:186-96.

10.

10. Hanshaoworakul W, Simmerman JM, Narueponjirakul U, Sanasuttipun W, Shinde V, Kaewchana S, et al. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS One 2009;4:e6051.

11.

11. ANZIC Influenza Investigators, Webb SA, Pettila V, Seppelt I, Bellomo R, Bailey M, et al. Critical care services and 2009H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;361:1925-34.

12.

12. Dominguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009;302:1880-7.

13.

13. Furuya Y, Roberts S, Hurteau GJ, Sanfilippo AM, Racine R, Metzger DW. Asthma increases susceptibility to heterologous but not homologous secondary influenza. J Virol 2014;88:9166-81.

14.

14. Jain S, Benoit SR, Skarbinski J, Bramley AM, Finelli L; 2009Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Influenza-associated pneumonia among hospitalized patients with 2009 pandemic influenza A (H1N1)virus: United States, 2009. Clin Infect Dis 2012;54:1221-9.

15.

15. Garg S, Jain S, Dawood FS, Jhung M, Perez A, D’Mello T, et al. Pneumonia among adults hospitalized with laboratoryconfirmed seasonal influenza virus infection-United States, 2005-2008. BMC Infect Dis 2015;15:369.

16.

16. Kang SH, Cheong HJ, Song JY, Noh JY, Jeon JH, Choi MJ, et al. Analysis of risk factors for severe acute respiratory infection and pneumonia and among adult patients with acute respiratory illness during 2011-2014 influenza seasons in Korea. Infect Chemother 2016;48:294-301.

17.

17. Jeon MH, Chung JW, Choi SH, Kim TH, Lee EJ, Choo EJ. Pneumonia risk factors and clinical features of hospitalized patients older than 15 years with pandemic influenza A (H1N1) in South Korea: a multicenter study. Diagn Microbiol Infect Dis 2011;70:230-5.

18.

18. Riquelme R, Torres A, Rioseco ML, Ewig S, Cilloniz C, Riquelme M, et al. Influenza pneumonia: a comparison between seasonal influenza virus and the H1N1 pandemic. Eur Respir J 2011;38:106-11.

19.

19. Reed C, Chaves SS, Perez A, D’Mello T, Daily Kirley P, Aragon D, et al. Complications among adults hospitalized with influenza:a comparison of seasonal influenza and the 2009 H1N1pandemic. Clin Infect Dis 2014;59:166-74.

20.

20. Centers for Disease Control and Prevention (CDC). Intensive-care patients with severe novel influenza A (H1N1) virus infection: Michigan, June 2009. MMWR Morb Mortal Wkly Rep 2009;58:749-52.

21.

21. Hong KW, Cheong HJ, Choi WS, Lee J, Wie SH, Baek JH, et al. Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: hospital-based Influenza Morbidity & Mortality (HIMM) surveillance. J Infect Chemother 2014;20:9-14.

22.

22. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-86.

23.

23. Hinds AM, Bozat-Emre S, Van Caeseele P, Mahmud SM. Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada. BMC Public Health 2015;15:35.

Tuberculosis & Respiratory Diseases